Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial
暂无分享,去创建一个
M. Reni | E. Van Cutsem | J. Tabernero | W. Fang | T. Bekaii-Saab | D. Goldstein | S. Oh | Chung-Pin Li | T. Okusaka | T. Ioka | M. Ueno | M. Noel | Jonathan S. Goldberg | E. Foos | Do-Youn Oh | E. Anderson | J. Goldberg | Hye Jin Choi | Jian Li | C. Oh